Journal article icon

Journal article

Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design.

Abstract:

Tuberculosis remains a substantial global health problem despite effective drug treatments. The efficacy of BCG, the only available vaccine, is variable, especially in tuberculosis-endemic regions. Recent advances in the development of new vaccines against tuberculosis mean that the first of these are now entering into early clinical trials. A recombinant modified vaccinia virus Ankara expressing a major secreted antigen from Mycobacterium tuberculosis, antigen 85A, was the first new tubercul...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Jenner Institute
Role:
Author
Expand authors...
Journal:
The Lancet. Infectious diseases
Volume:
6
Issue:
8
Pages:
522-528
Publication date:
2006-08-05
DOI:
EISSN:
1474-4457
ISSN:
1473-3099
URN:
uuid:9ecb9424-8d34-4cea-854e-bbd159cf42dc
Source identifiers:
40007
Local pid:
pubs:40007

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP